Zimmer Biomet, US98956P1021

Zimmer Biomet stock heads into the open after a 3.3 percent gain

Published on 09/16/2026 at 03:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 15, 2026, Zimmer Biomet stock finished at USD 96.54 on the NYSE, up 3.3 percent. The move came with volume of 3.62 million shares, above the average, while the Nasdaq Composite fell 0.6 percent.

Titan-Knieimplantat auf Edelstahltisch in steriler Medizintechnik-Fertigung
Zimmer Biomet US98956P1021 zeigt Titan-Knieimplantat mit orthopädischen Instrumenten in steriler Fertigungsumgebung nahaufnahme, Illustration mit AI erstellt.

Zimmer Biomet stock closed at USD 96.54 on the NYSE on September 15, 2026, up 3.3 percent from the previous close. Volume reached 3,615,966 shares, above the average of 2,264,630, and the stock ended between its 52-week low of USD 79.12 and high of USD 106.88.

Zimmer Biomet Holdings, Inc. (ISIN US98956P1021) rose after ad hoc news reported a leadership reshuffle that followed the departure of Kevin Thornal and the promotion of other senior executives. The same report also noted that the stock's latest close remained about 10.3 percent below its 52-week high and about 21.9 percent above its 52-week low.

Today, a quarterly dividend date of September 30, 2026 remains on the calendar, with a cash payment of USD 0.24 per share cited in market reports. The broader market backdrop is mixed: The Motley Fool reported that the S&P 500 was down 0.6 percent and the Nasdaq Composite 0.6 percent in the last session, a backdrop that may also shape trading in health care shares today.

Disclaimer...

en | US98956P1021 | ZIMMER BIOMET | boerse | 70107576 | bgmi